GlassScriptPhysician profile
Gary W Cannon
NPI 1659357051
$8,029.48
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,973 · 2020: $1,145 · 2021: $2,447 · 2022: $1,990 · 2023: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $921.08 | 2019-2022 | |
| Novo Nordisk INC | $621.02 | 2019-2023 | Rybelsus, Ozempic |
| Pfizer INC. | $610.91 | 2019-2023 | |
| Glaxosmithkline, LLC. | $606.24 | 2019-2023 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $483.06 | 2019-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $480.17 | 2019-2023 | Xarelto |
| Amgen INC. | $480.00 | 2019-2023 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $407.01 | 2019-2023 | Steglatro, Belsomra |
| Takeda Pharmaceuticals U.S.A., INC. | $387.12 | 2019-2023 | Trintellix |
| Lilly USA, LLC | $380.01 | 2019-2023 | Mounjaro, Trulicity |
| Abbvie INC. | $367.49 | 2021-2023 | Ubrelvy, Qulipta |
| Kowa Pharmaceuticals America, INC. | $343.73 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $278.61 | 2019-2023 | Trulance, Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $169.16 | 2019-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $155.75 | 2019-2023 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $136.17 | 2022 | |
| Antares Pharma, INC. | $134.59 | 2019-2021 | |
| Esperion Therapeutics, INC. | $134.01 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.18 | 2022-2023 | |
| Amarin Pharma, INC. | $99.15 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $94.90 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $87.77 | 2021 | |
| Kaleo, INC. | $86.50 | 2019-2022 | |
| Eisai INC. | $77.75 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $77.42 | 2020-2022 | |
| Genentech USA, INC. | $60.55 | 2019-2022 | |
| Astellas Pharma US INC | $56.73 | 2019-2023 | Veozah, Myrbetriq |
| Allergan, INC. | $32.28 | 2020 | |
| Aytu Biopharma, INC. | $24.28 | 2019 | |
| Biogen, INC. | $16.11 | 2021 | |
| Shire North American Group INC | $16.06 | 2019 | |
| Abbott Laboratories | $15.26 | 2020 | |
| Sanofi Pasteur INC. | $15.05 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.68 | 2020 | |
| Idorsia Pharmaceuticals US INC | $13.53 | 2023 | Quviviq |
| Adlon Therapeutics L.P. | $13.06 | 2020 | |
| Avanir Pharmaceuticals, INC. | $12.02 | 2021 | |
| Alk-Abello, INC | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Cannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.